![Adi Mohanty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adi Mohanty
Directeur Général chez
BIORA THERAPEUTICS, INC.
Profil
Aditya P.
Mohanty was the founder of EnCellX, Inc. founded in 2019, where he served as the Chief Executive Officer until 2021.
Currently, he is the Chief Executive Officer & Director at Biora Therapeutics, Inc. and a Director at Cell Cure Neurosciences Ltd. Mr. Mohanty's former positions include President, Co-Chief Executive Officer & Director at Lineage Cell Therapeutics, Inc., Director at Asterias Biotherapeutics, Inc., Director at OncoCyte Corp., Vice President-Manufacturing & Operations at Transkaryotic Therapies, Inc. and Shire Human Genetic Therapies, Inc., and President-Regenerative Medicine at Shire Plc.
Mr. Mohanty's education includes a graduate degree from Clarkson University, an MBA from St. Mary's College (Indiana), and an undergraduate degree from National Institute of Technology Tiruchirappalli.
Postes actifs de Adi Mohanty
| Sociétés | Poste | Début |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Directeur Général | 08/11/2021 |
Cell Cure Neurosciences Ltd.
 Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Develops cell therapies for neural degenerative diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Adi Mohanty
| Sociétés | Poste | Fin |
|---|---|---|
EnCellX, Inc.
 EnCellX, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immune optimization solutions | Directeur Général | 01/11/2021 |
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Directeur/Membre du Conseil | 17/06/2020 |
| LINEAGE CELL THERAPEUTICS, INC. | Directeur Général | 17/09/2018 |
| ASTERIAS BIOTHERAPEUTICS INC | Directeur/Membre du Conseil | 08/03/2018 |
| SHIRE | Corporate Officer/Principal | 01/01/2014 |
Formation de Adi Mohanty
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Commercial Services |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes regenerative medicine for neurology and oncology applications | Health Technology |
Clarkson University
 Clarkson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Mary's College (Indiana)
 St. Mary's College (Indiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Health Technology |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Develops cell therapies for neural degenerative diseases | Health Technology |
OncoCyte Corp.
 OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
Biora Therapeutics, Inc.
 Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases | Health Technology |
National Institute of Technology Tiruchirappalli
 National Institute of Technology Tiruchirappalli Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EnCellX, Inc.
EnCellX, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immune optimization solutions | Health Technology |
Choisissez Zonebourse 
